Neupro® - Restless Legs Syndrome
Europe
In Europe, Neupro® is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
Prescribing information Europe
USA
In the US, Neupro® (Rotigotine Transdermal System) is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome.
Prescribing information USA
-
US prescribing information Neupro®
July-2021 | pdf file, 1101 kb
Other countries
For availability of Neupro® in other countries, please consult our local websites.